Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nupur Das
Institutions:
Amrita Institute of Medical Sciences and Research Centre,
Gauhati Medical College and Hospital,
Amrita Vishwa Vidyapeetham
Observed institutions:
Amrita Institute of Medical Sciences and Research Centre,
Gauhati Medical College and Hospital,
DR. B.R.A. Institute Rotary Cancer Hospital,
All India Institute of Medical Sciences,
Amrita Vishwa Vidyapeetham
ORCID:
0000-0001-7025-6210
Observed ORCID:
0000-0001-7025-6210
OpenAlex ID:
A5049112089
A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML
2020
·
Nupur Das
, Ritu Gupta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
38
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study
2022
·
Prashant Sirohiya
, Arunmozhimaran Elavarasi
, et al.
·
Lung India
·
24
Cell-free DNA for genomic profiling and minimal residual disease monitoring in Myeloma- are we there yet?
2020
·
Deepshi Thakral
, Nupur Das
, et al.
·
PubMed
·
21
The Effectiveness of SARS-CoV-2 Vaccination in Preventing Severe Illness and Death – Real-World Data from a Cohort of Patients Hospitalized with COVID-19
2022
·
Hari Krishna Raju Sagiraju
, Arunmozhimaran Elavarasi
, et al.
·
Indian Journal of Community Medicine
·
15
Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma
2022
·
Nupur Das
, Meetu Dahiya
, et al.
·
Cytometry Part B Clinical Cytometry
·
15
Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders
2022
·
Garima Jain
, Nupur Das
, et al.
·
International Journal of Laboratory Hematology
·
13
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition
2022
·
Nupur Das
, Meetu Dahiya
, et al.
·
Cytometry Part B Clinical Cytometry
·
13
Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort study
2021
·
Arunmozhimaran Elavarasi
, Hari Krishna Raju Sagiraju
, et al.
·
Lung India
·
13
Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10‐colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity
2024
·
Nupur Das
, Devasis Panda
, et al.
·
International Journal of Laboratory Hematology
·
11
PDF
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL
2021
·
Nupur Das
, Ritu Gupta
, et al.
·
Annals of Hematology
·
9
The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India
2023
·
Tanima Dwivedi
, Apurva Raj
, et al.
·
Cureus
·
8
PDF
Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma —An evidence‐based approach
2022
·
Sandeep Rai
, Nupur Das
, et al.
·
International Journal of Laboratory Hematology
·
6
Genomic landscape of mature B-cell non-Hodgkin lymphomas — an appraisal from lymphomagenesis to drug resistance
2022
·
Devasis Panda
, Nupur Das
, et al.
·
Journal of the Egyptian National Cancer Institute
·
5
PDF
Graded Depth of Response and Neoplastic Plasma Cell Index as Indicators of Survival Outcomes in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant
2022
·
Nupur Das
, Meetu Dahiya
, et al.
·
American Journal of Clinical Pathology
·
4
FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor
2019
·
Ritu Gupta
, Nupur Das
, et al.
·
Indian Journal of Pathology and Microbiology
·
4
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in India
2025
·
Smeeta Gajendra
, Tanima Dwivedi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
Risk stratification in multiple myeloma – A review and update
2024
·
Nupur Das
, Ritu Gupta
·
Annals of the National Academy of Medical Sciences (India)
·
3
Persistence of SARS-CoV-2 Antibodies for a Year Following SARS-CoV-2 Vaccinations (BBV152 and ChAdOx1 nCoV-19)
2023
·
Tanima Dwivedi
, Apurva Raj
, et al.
·
Indian Journal of Clinical Biochemistry
·
3
PDF
Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update
2023
·
Nupur Das
, Smeeta Gajendra
, et al.
·
Indian Journal of Hematology and Blood Transfusion
·
2
PDF
Real-world experience with inotuzumab ozogamicin in high-risk and R/R B-cell acute lymphoblastic leukemia.
2026
·
Anshul Jain
, Prashant Mehta
, et al.
·
Journal of Clinical Oncology
·
1
CD 19 CAR T-Cell Therapy in R/R B Cell Malignancies : A Real World Experience from CAR T Working Group, Delhi Ncr ,India
2024
·
Prashant Mehta
, Pravas Mishra
, et al.
·
Blood
·
1
Voyage of Measurable Residual Disease Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry
2023
·
Nupur Das
, Ritu Gupta
·
Indian Journal of Medical and Paediatric Oncology
·
1
PDF
Stillbirth Rate, Feto-Maternal Characteristics and Geographical Distribution at a Tertiary Care Centre in Assam: A Hospital-Based Retrospective Cross-Sectional Study
2026
·
Nupur Das
, Mandeep Bayan
, et al.
·
National Journal of Medical Research
PDF
Real-world insights into genomic reprogramming during CAR-T cell manufacturing in India
2026
·
Nupur Das
, Prashant Mehta
, et al.
·
Frontiers in Immunology
PDF
Comprehensive leucocyte subsets assay in healthy adults using multiparametric flowcytometry
2026
·
Nupur Das
, Rahul Katharia
, et al.
·
The Indian Journal of Medical Research
PDF
Show more works
View as search
Works count:
48
Citation count:
213
H-index:
9
I10-index:
9
Year
Topic
Type